|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
J.R. 22
|
|
|
|
|
|
2002 JOINT RESOLUTIONS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Assembly on or before December 1, 2002, in accordance with § 2-1246 of the State
Government Article, on measures, such as production credits, construction bonds or
other incentives that would attract producers to develop an ethanol production plant
in Maryland that will be fully on-line and operating at capacity in 2004 the feasibility
of developing an ethanol production facility in Maryland, including examination of
proposed operational structures, financing, State incentives, and other matters
related to proceeding with development of the facility; and be it further
RESOLVED, That a copy of this Resolution be forwarded by the Department of
Legislative Services to the Honorable Parris N. Glendening, Governor of Maryland;
the Honorable Thomas V. Mike Miller, Jr., President of the Senate of Maryland; and
the Honorable Casper R. Taylor, Jr., Speaker of the House of Delegates.
Signed May 16, 2002.
|
|
|
|
|
|
|
|
|
|
Joint Resolution No. 22
(House Joint Resolution No. 1)
A House Joint Resolution concerning
Ovarian Cancer Awareness Month
FOR the purpose of designating September of each year as "Ovarian Cancer
Awareness Month".
WHEREAS, Each year, while approximately 82,000 women in the United States
are diagnosed with cancers affecting the reproductive organs, ovarian cancer is the
most serious form of gynecologic cancers, killing approximately 40 women a day,
accounting for 4% of all cancers among women, and ranking fifth as a cause of their
deaths from cancer;
WHEREAS, Public health experts estimate that over 23,000 women in the
United States will be diagnosed with ovarian cancer in 2001 2002, with one woman
out of every 55 developing ovarian cancer at some point in her life;
WHEREAS, Public health experts estimate that over approximately 14,000
women in the United States will die from ovarian cancer in 2001 2002;
WHEREAS, Public health experts estimate that 200 women in the State of
Maryland will die from ovarian cancer in 2002;
WHEREAS, Ovarian cancer is often referred to as the "silent killer" because the
symptoms are often subtle, vague, and easily confused with other ailments, making it
difficult to diagnose and thus allowing this lethal malignancy the opportunity to
spread through a woman's abdomen and beyond before being detected;
WHEREAS, Over 75% of women diagnosed with ovarian cancer are not
diagnosed until the cancer has spread beyond the ovaries, resulting in a 5-year
survival rate of only 15% to 20%;
|
|
|
|
|
|
|
|
|
|
- 4374 -
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
